Concept

Endoluminal Solutions Inc., a startup founded in 2025 originating from Osaka University, is developing the world's first screening-specific disposable endoscope (gastroscope) designed to address structural challenges in gastric cancer screening.
The company is led by founder representative and director Kiyokazu Nakajima (Professor of the Osaka University), who brings 30 years of experience as a surgeon and 20 years in medical device development. Backed by a proven track record of collaborations with over 50 companies, commercialization of more than 30 products, and over 160 patent applications, the company is advancing this innovative initiative.
By delivering practical solutions that directly respond to real clinical needs, we aim to fundamentally transform Japan's cancer screening system for the first time in half a century.

Challenge

ディスポーザブル胃カメラで従来の検診を変える

Gastric cancer screening, undergone by tens of millions of people annually, has relied primarily on barium-based X-ray examinations for over half a century.
However, barium screening has significant: it offers relatively low cancer detection accuracy while exposing patients to radiation, and it carries risks such as bowel obstruction and fall-related accidents.
On the other hand, endoscopic examination provides higher detection accuracy, but there is currently no endoscope specifically designed for screening. Instead, and complex endoscopes originally developed for diagnostic and therapeutic procedures are used. These devices are large and require time-consuming processes for cleaning, disinfection, and drying, making them unsuitable for large-scale screening.
To address these challenges, we are developing the world's first screening-specific disposable endoscope (gastroscope), optimized exclusively for screening purposes.
With an ultra-thin diameter of just 4 mm and a fully single-use design, our device minimizes patient discomfort, eliminates infection risk, and removes downtime associated with reprocessing—enabling efficient large-scale screening.
Combined with an AI-powered diagnostic support system tailored for screening, our solution aims to improve early detection rates of gastric cancer while contributing to the reduction of overall healthcare costs.

  • バリウムの問題点

    Problems with Valium

    The Con
    with Barium Testing

    View more

  • 内視鏡の問題点

    Problems with Endoscopes

    Limitations of
    Conventional
    Endoscopy

    View more

  • 開発商品紹介

    Development product introduction

    Our

    View more

中島 清⼀

Endoluminal Solutions Inc.

Founder representativeKiyokazu Nakajima,
MD, PhD, FACS

Message Message

Message Message

中島 清⼀

message from Founder representative

Endoluminal Solutions Inc. is a company born from real, unmet needs in clinical practice.
The challenges experienced in the operating room as a surgeon, the opportunities identified as a medical device developer, and the fundamental value learned through work in emerging markets—these experiences have come together to create a groundbreaking solution: a screening-specific disposable endoscope (gastroscope).
We are not simply a product. We aim to transform Japan's screening system, create new possibilities for surgeons, and contribute to improving healthcare worldwide. Our name embodies this mission—to generate solutions from developing within the body's lumen (“endoluminal”).
As we move steadily toward market launch around 2029 to early 2030, we invite you to follow and support our journey.

大阪大学大学院医学系研究科次世代内視鏡治療学共同研究講座大阪大学大学院医学系研究科次世代内視鏡治療学共同研究講座

Career

1992
Graduated from Osaka University School of Medicine and trained at the First Department of Surgery.
1999
Completed the doctoral course at the same university (medical doctorate).
2001-2003
2001-2003
He is engaged in clinical research in minimally invasive surgery at the Department of Surgery at Cornell University (New York).
2004
After serving as chief surgeon at Osaka Rosai Hospital, he joined the Department of Gastroenterological Surgery at Osaka University in 2006.
2008
The world's first successful resection of a gastric tumor using transluminal endoscopic surgery (NOTES).
Since then, he has continued to work at the forefront of clinical practice as a surgeon, while also leading the research and development of medical devices that will enable next-generation endoscopic treatment.
2012
Since that year, he has been a professor in the Department of Next Generation Endoscopic Therapy at Osaka University.
With grants from the Ministry of Economy, Trade and Industry, the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare, and the Japan Agency for Medical Research and Development (AMED),
To date, the company has achieved success by launching 28 products, including several major hits, filing over 160 patent applications, and publishing numerous academic papers in English.
2023
As an “Innovation Producer” of the Small and Medium Enterprise Agency from fiscal year 2011,
The company is also actively involved in supporting innovation creation for small and medium-sized enterprises.

Member

icon arrow
icon arrow
苗字 名前
01

Representative DirectorTakuya Kimura

苗字 名前
02

COO and Co-FounderTakuya Kanda

苗字 名前
03

Director and CTOMakoto Hosaka

苗字 名前
04

Director/Co-founderTakanori Yakuwa

清和 寿光
05

Medical AdvisorToshimitsu Seiwa

東原 大樹
06

Medical AdvisorDaiki Higashihara

加藤 勝章
07

Medical AdvisorKatsuaki Kato

icon arrow
icon arrow

Office

Company Name
endoluminal solutions, Inc.
”University Startup(The University of Osaka)”
Business content
・Design, development, manufacturing, sales, manufacturing and sales, export and import of medical devices
・Management, marketing, human resource development and consulting related to the above
address
〒541-0045
Osaka Prefecture, Osaka City, Chuo Ward, Doshomachi 4-1-1, Takeda Midosuji Building No. 220